Compare RVMD & CF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RVMD | CF |
|---|---|---|
| Founded | 2014 | 1946 |
| Country | United States | United States |
| Employees | 883 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Agricultural Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.2B | 20.0B |
| IPO Year | N/A | 2005 |
| Metric | RVMD | CF |
|---|---|---|
| Price | $135.72 | $121.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 17 | 15 |
| Target Price | ★ $120.47 | $111.21 |
| AVG Volume (30 Days) | 1.6M | ★ 4.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | N/A | ★ 33.09 |
| EPS | N/A | ★ 8.97 |
| Revenue | N/A | ★ $7,084,000,000.00 |
| Revenue This Year | N/A | $0.78 |
| Revenue Next Year | $411.49 | N/A |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | ★ 19.34 |
| 52 Week Low | $34.00 | $72.09 |
| 52 Week High | $124.49 | $141.96 |
| Indicator | RVMD | CF |
|---|---|---|
| Relative Strength Index (RSI) | 83.53 | 48.59 |
| Support Level | $93.39 | $79.73 |
| Resistance Level | N/A | $139.70 |
| Average True Range (ATR) | 3.63 | 6.77 |
| MACD | 2.68 | -2.37 |
| Stochastic Oscillator | 96.51 | 33.14 |
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
CF Industries is a leading producer and distributor of nitrogen, which is primarily used in fertilizers. The company operates nitrogen manufacturing plants primarily in North America. CF also produces nitrogen in the United Kingdom and holds a joint venture interest in a nitrogen production facility in Trinidad and Tobago. CF makes nitrogen primarily using low-cost US natural gas as its feedstock, making the company one of the lowest-cost nitrogen producers globally. It is also investing in carbon-free blue and green ammonia, which can be used as an alternative fuel to hydrogen or as a means to transport hydrogen.